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ABSTRACT 
American Indians/Alaska Natives (AI/AN) diagnosed with HIV infection have poorer 
survivorship and a higher percentage of Stage 3 (AIDS] diagnoses within one year of HIV 
diagnosis, compared to most race/ethnicity groups. National HIV surveillance data for 2008-
2011 were used to determine diagnosis rates of HIV infection, persons living with HIV, and 
persons with a late diagnosis (Stage 3 within three months of HIV diagnosis) by selected 
characteristics for AI/AN and a combined other race/ethnicity group. The highest percentages 
of 862 AI/AN diagnosed with HIV infection were among males (75.7%),  AI/AN aged 25-34 
years (32.9%), persons living in large metropolitan areas (53.4%), and those diagnosed in 
outpatient facilities (39.4%). Among males, the majority of infections were attributed to 
male-to-male sexual contact (MSM) (71.8%). The percentage of infections attributed to 
injection drug use (IDU) for AI/AN females (28.5%) was greater than the other race/ethnicity 
group (15.2%). Probability of late diagnosis among AI/AN males was associated with: age 
>35 years, and diagnosis in emergency room or hospital, or outpatient settings, and among 
AI/AN females, diagnosis in hospital or emergency room. Early detection of HIV infection 
along with linkage to and retention in care are important for all populations, including 
AI/AN. Routine HIV screening at a variety of public health and outpatient facilities, and 
linkage to care are important to decrease HIV transmission and improve survival. 
Keywords: American Indian/Alaska Native, human immunodeficiency virus, HIV/AIDS, 
Surveillance, Indian Health 
 
INTRODUCTION 
According to the 2010 U.S. Census, a total of 5.2 million individuals reported their race 
as American Indian or Alaska Native (AI/AN), representing 1.7% of the U.S. population, 
including 2.9 million reporting AI/AN race alone and 2.3 million reporting AI/AN in 
combination with one or more other races (U.S. Census, 2012a). The Indian Health Service 
(IHS) funds health care for an estimated 2.1 million AI/AN, consisting of IHS direct health care 
services, tribally operated health care systems, and urban Indian health care centers (I/T/U) (IHS, 
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2011; Bertolli et al., 2008). In addition, many AI/AN receive health services from the usual 
public and private providers utilized by other Americans. Because AI/AN from recognized tribes 
living in certain geographic areas are eligible for free care through these tribal health systems, 
some AI/AN theoretically could have increased access for HIV testing and treatment than other 
populations.   
While the total number of diagnoses of HIV infection reported annually in the United 
States for American Indian/Alaska Natives (AI/AN) is relatively small compared to the burden 
of HIV disease nationally, estimated rates of HIV infection are higher among AI/AN than some 
race/ethnicity groups (Asians and whites), with 9.3 AI/AN diagnosed per 100,000 population in 
2011 (CDC 2013a). High rates of sexually transmitted diseases (STDs) among AI/AN 
populations, 4.1 and 4.6 times the rates among non-Hispanic whites for chlamydia and for 
gonorrhea respectively, demonstrate that AI/AN are at additional risk for acquiring or 
transmitting HIV infection (CDC, 2012a).  
AI/AN have been reported to be disproportionately affected by HIV in terms of late 
diagnosis and lower survivorship (CDC, 2013a; CDC, 2009).  In 2010, AI/AN had the second 
highest percentage (38%) of stage 3 HIV (AIDS) diagnosis within 1 year of initial HIV diagnosis 
compared to all other race/ethnicity groups (CDC, 2013a). AI/AN diagnosed during 2003-2007 
had the lowest survival rate at 12, 24 and 36 months after an HIV diagnosis, compared to all 
other race/ethnicity groups except persons of multiple races (CDC, 2013a). A larger estimated 
percentage of AI/AN infected with HIV (24.7%) were undiagnosed by the end of 2009, 
compared to blacks/African Americans, Hispanics/Latinos and whites, potentially contributing to 
ongoing transmission (CDC, 2012b. Together, these statistics suggest late testing, late initiation 
of care, and lack of treatment or poor retention in care among AI/AN as compared to other 
race/ethnicity groups. 
The objective of this analysis was to characterize the public health impact of HIV disease 
in 2008-2011 among AI/AN adults and adolescents aged >13 years in the United States by 
demographics, transmission category, facility at diagnosis, and geographic factors, using four 
years of combined national surveillance data, in order to guide HIV prevention efforts .  A 
second objective was to determine factors associated with late diagnosis and identify subgroups 
that may need additional attention for earlier testing and initiation of treatment.  
 
METHODS 
Data Collection 
Case reports from the Centers for Disease Control and Prevention’s (CDC) HIV 
surveillance system were used to calculate rates of HIV diagnoses and rates of living with a 
diagnosis of HIV infection (CDC, 2013a). Diagnoses of HIV infection are reported without 
personal identifiers to the National HIV Surveillance System (NHSS) by all states, the District of 
Columbia, and U.S. territories.  New diagnoses of HIV infection made in IHS-funded facilities 
are expected to be reported to state or local health departments by providers and laboratories 
licensed in the state, even in facilities located in federally recognized tribal areas. With an 
estimated average of 216 new HIV diagnoses reported among AI/AN annually (CDC, 2013a), 
annual rates by demographics, risk factors, geographic region, and clinical characteristics, based 
on relatively small numbers, can be unstable from year to year, leading to difficulty in 
distinguishing random fluctuation from true changes in underlying risk of infection. Therefore, 
combined data for persons diagnosed from 2008-2011 were used to allow for comparison of 
AI/AN to a combined other race/ethnicity group for selected characteristics. AI/AN were defined 
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as persons having a race classification of AI/AN only and did not include Hispanic AI/AN or 
multi-race AI/AN. To focus on the epidemiology of HIV among AI/AN, and not on other 
individual race/ethnicity groups, some of which have much greater rates of HIV diagnoses, the 
rest of the U.S. population was combined into a single “other race/ethnicity group,” a category 
comprised of Asian, black or African American, Hispanic or Latino (any race), Native Hawaiian 
or other Pacific Islander, white, and multi-race persons (including some multi-race AI/AN). HIV 
diagnosis rates by separate race/ethnicity groups are published annually (CDC, 2013a). 
Data Analysis 
We estimated the number, percentage, and average annual rates per 100,000 population 
for adults and adolescents aged >13 years diagnosed with HIV infection, regardless of stage of 
disease at diagnosis, during 2008-2011. Diagnoses of HIV reported to CDC through June 2012 
from all 50 states and the District of Columbia (DC) (CDC, 2013a) were used. Rates of persons 
living with a diagnosis of HIV infection (prevalence) were based on individuals living at the end 
of 2010 who had been diagnosed in any year prior to and including 2010. Population 
denominators for the rates of HIV infection and AIDS were calculated using official post-censal 
estimates from the U.S. Census Bureau (U.S. Census, 2012b). The number of persons living with 
a diagnosis of HIV infection was assessed at the end of 2010 to allow at least 18 months for 
delays in reports of death information. Three levels of population density for area of residence at 
diagnosis were used based on the 2009 Office of Management & Budget’s (OMB) definitions of 
metropolitan statistical areas (MSAs), with 2 urban categories of large metropolitan areas with a 
population of 500,000 or more persons and metropolitan areas with 50,000 to 499,999 persons, 
and one non-metropolitan category (rural) with less than 50,000 persons (OMB, 2009).  Ten-year 
age groups were used for the main analyses of diagnoses of HIV infection, except for the 13-14 
year old group, which had no AI/AN diagnoses; age groups were further combined to provide 
sufficient numbers for the multivariate modeling for late diagnosis. Pearson chi-square statistics 
were calculated using SAS version 9.3 (SAS Institute, Cary, NC) to assess differences across the 
two groups (late diagnosis vs. no late diagnosis) and prevalence ratios (PR) were used to assess 
differences within substrata of a group, for example, age categories for AI/AN (Spiegelman & 
Hertzmark, 2005). Calculations for chi-squares and prevalence ratios for population density of 
area of residence excluded persons without information on residence at diagnosis. 
Definitions of Characteristics 
Persons diagnosed with HIV infection were stratified by sex and HIV transmission risk 
factor and classified into the following hierarchy of transmission categories: 1) male-to-male 
sexual contact (men who have sex with men, MSM), including males who report sexual contact 
with both men and women, 2) injection-drug use (IDU), 3) both male-to-male sexual contact and 
injection-drug use (MSM/IDU), 4) heterosexual contact with a person of the opposite sex known 
to have HIV or be at high risk for HIV infection, and 5) all other risk factors combined (e.g., 
hemophilia and blood transfusion) (CDC, 2013a). Data were statistically adjusted for reporting 
delays and multiple imputation was used to assign transmission categories for cases missing risk 
factor information (Song & Green, 2012; McDavid et al., 2008). In 53 of 59 HIV surveillance 
project areas fewer than 30% of diagnoses of HIV infection reported in 2011 were missing risk 
factor information (Karch, Chen, & Tang, 2013). Facility type at diagnosis of HIV infection was 
grouped into 4 main categories: 1) CTS/STD/screening, including HIV counseling and testing 
sites (CTS), STD clinics, family planning, and other screening, diagnostic and referral agencies 
such as blood banks and insurance screening;  2) inpatient/emergency room (ER), including 
hospitals, long-term inpatient facilities and emergency rooms; 3) outpatient, including private 
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physician offices, as well as adult and pediatric, TB, drug treatment, community, mobile and 
other clinics; and 4) other, including correctional facilities and medical examiner offices. 
A late HIV diagnosis was defined as a diagnosis of stage 3 HIV infection (AIDS) within 
3 months of the date of diagnosis with HIV infection. The analysis was limited to adults and 
adolescents newly diagnosed during 2008-2010 to allow additional time for reports of stage 3 
HIV infections. Prevalence ratios for the univariate and multivariate analyses were estimated 
using the log binomial regression method (Spiegelman & Hertzmark, 2005) and were considered 
significant if the 95% confidence interval (CI) of the prevalence ratio did not include one (1.0) or 
if the P-value was less than 0.05. The multivariate analysis was stratified by sex because of the 
differences in transmission categories among males compared with females, and retained 
variables that had at least one significant value (P <.05) in the univariate analysis. 
Residence in a county where the Indian Health Service provides health care services (IHS 
service county) was used as a proxy for greater access to IHS-funded facilities, compared to less 
access in other counties. It was defined using previously developed methodology (CDC & IHS, 
2009), consisting of residency in any of 625 IHS service counties included in one of 12 regional 
administrative units called Area Offices in 35 states (GAO, 2007). The rates represent diagnoses 
of HIV infection for all AI/AN residing in the IHS service counties, including those diagnosed in 
health care facilities not funded by IHS. 
 
RESULTS 
Diagnoses of HIV Infection 
Among the 862 AI/AN adults and adolescents diagnosed during 2008-2011 (Table 1), the 
highest percentage of new diagnoses were among males (75.7%), individuals aged 25-34 years 
(32.9%), individuals diagnosed in an outpatient facility (39.4%), and individuals living in large 
metropolitan  areas (53.4%). The majority of HIV infections diagnosed among males were 
attributed to male-to-male sexual contact (71.8%), similar to the other race/ethnicity group 
(76.4%). The percentage of new diagnoses among AI/AN females (24.3%) was similar to the 
other race/ethnicity group (22.5%), but the percentage of HIV infections attributed to injection 
drug use (IDU) among females (28.5%) was significantly higher than that for the other 
race/ethnicity group (15.2%, chi-square = 28.4869, P <.0001). The percentage of HIV infections 
attributed to IDU (9.0%) was higher among AI/AN males than among males in the other 
race/ethnicity group (6.8%, chi-square = 5.0000, P= 0.0253) and the percentage attributed to 
both male-to-male sexual contact and injection drug use (MSM/IDU), 10.0%, was also higher 
than that for the other race/ethnicity group (4.1%, chi-square = 57.2890, P <.0001). The 
percentage of HIV infections among AI/AN males attributed to heterosexual contact (9.0%) was 
significantly lower than for the other race/ethnicity group (12.7%, chi-square = 7.8424, P = 
0.0051).  Of AI/AN diagnosed with HIV infection, 25.9% lived in non-metropolitan (rural) areas 
with populations less than 50,000 people, compared to 6.4% for the other race/ethnicity group 
(chi-square = 550.3863, P <.0001). Nevertheless, more than two-thirds (72.5%) of HIV-infected 
AI/AN lived in urban areas at HIV diagnosis.  
Rates of HIV Diagnosis 
The estimated average annual rate of new diagnoses of HIV infection per 100,000 
population for 2008-2011 among AI/AN adults and adolescents was 11.7, compared to 18.9 in 
the other race/ethnicity group (Table 1). The AI/AN diagnosis rate per 100,000 among males was 
three times that of females (18.1 vs. 5.6), but both rates were lower than for males and females in 
the other race/ethnicity group, 30.1 and 8.3, respectively. The HIV diagnosis rate of 16.1 per 
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100,000 for AI/AN living in large metropolitan areas at the time of diagnosis was considerably 
lower than the same rate for the other race/ethnicity group (23.7), but the rates were similar for 
AI/AN and the other race/ethnicity group living in smaller metropolitan and rural areas (Table 
1). 
Living with a Diagnosis of HIV infection 
At the end of 2010, an estimated 3,187 AI/AN adults and adolescents were living with a 
diagnosis of HIV infection for a rate of 176.4 per 100,000 population (Table 2). Of these, 73.8% 
were male and 26.2% were female, with a rate among males (265.9 per 100,000) that was almost 
3 times the rate among females (90.6 per 100,000). The highest rates of AI/AN living with HIV 
infection were among those aged 35-44 years (342.8 per 100,000) and those aged 45-54 years 
(310.2 per 100,000). The majority of AI/AN living with a diagnosis of HIV infection resided in a 
large metropolitan area when first diagnosed (61.4%). By transmission category, the majority of 
HIV infections among AI/AN males was attributed to male-to-male sexual contact (64.6%) and 
among females was attributed to heterosexual contact (65.2%). For females, the percentage of 
HIV infections attributed to IDU (31.8%) was higher among AI/AN than in the other 
race/ethnicity group (25.0%). For males, the percentage of HIV infections among AI/AN 
attributed to MSM/IDU (16.2%) was more than twice the percentage among the other 
race/ethnicity group (7.4%). 
Late Diagnosis of HIV Infection 
Late diagnosis, i.e., stage 3 HIV infection (AIDS) within 3 months of diagnosis, among 
all AI/AN adult and adolescents diagnosed during 2008-2010 did not differ significantly from 
that of the other race/ethnicity group (29.0% v. 27.7% [data not shown], chi-square = 0.5460, P= 
0.4599).  Among AI/AN, there was no statistically significant difference in the probability of late 
diagnosis for males compared to females (PR=1.20, CI 0.89, 1.62, P=0.2388) (Table 3).  
In the univariate analysis, the probability of late HIV diagnosis among AI/AN differed by 
age, facility of diagnosis, and residence in a county with IHS health facilities (Table 3) but not 
by sex, male or female transmission category, or population density of area of residence. The 
probability of late diagnosis increased with advancing age, especially for AI/AN aged 35-44 
years (PR = 1.86, CI 1.10, 3.12, P= 0.0197) and 45 years and older (PR = 2.72, CI 1.65, 4.48, 
P< 0.0001), compared to the youngest group (13-24 years).  Compared to AI/AN diagnosed at 
CTS/STD facilities, the probability of late diagnosis was higher for AI/AN diagnosed in 
outpatient settings (PR 5.0, CI 2.25, 11.13, P < 0.0001), in inpatient/ER facilities (PR 10.1, CI 
4.62, 22.30, P <.0001), and in other facilities (PR 4.66, CI 1.79, 12.14, P = 0.0016). AI/AN 
residing in IHS service counties had a higher probability of late diagnosis (PR 1.49, CI 1.13, 
1.96, P = 0.0050), compared to AI/AN living in counties without IHS health facilities.  
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Characteristic Total
No. % Rate
b No. % Rate
b No. %
Sex
Male 652 75.7 18.1 148,585  77.5 30.1      149,238 77.5
Female 210 24.3 5.6 43,122     22.5 8.3        43,332 22.5
Age group at diagnosis (yrs)
13-14 0 0.0 172          0.1 0.5              172 0.1
15-24 139 16.1 8.8 37,943     19.8 22.1        38,081 19.8
25-34 284 32.9 21.6 51,932     27.1 31.6        52,216 27.1
35-44 220 25.6 18.3 47,356     24.7 28.8        47,576 24.7
45-54 153 17.8 11.9 37,282     19.4 21.0        37,435 19.4
55-64 52 6.1 5.6 13,495     7.0 9.5        13,547 7.0
65+ 14 1.6 1.8 3,528       1.8 2.2           3,542 1.8
HIV transmission category - Male
Male-to-male sexual contact 468 71.8 − 113,453  76.4 −      113,921 76.3
Injection drug use 59 9.0 − 10,075     6.8 −        10,134 6.8
Male-to-male sexual contact and injection drug use 65 10.0 − 6,087       4.1 −           6,152 4.1
Heterosexual contact
c
59 9.0 − 18,811     12.7 −        18,870 12.6
Other
d
1 0.2 − 160          0.1 −              161 0.1
HIV transmission category - Female
Injection drug use 60 28.5 − 6,552       15.2 −           6,612 15.3
Heterosexual contact
c
149 71.2 − 36,485     84.6 −        36,634 84.5
Other
d
1 0.3 − 85             0.2 −                86 0.2
Facility type at diagnosis
CTS/STD
e
151 17.5 − 31,167     16.3 −        31,318 16.3
Inpatient/ER 183 21.2 − 37,064     19.3 −        37,247 19.3
Outpatient 340 39.4 − 71,376     37.2 −        71,715 37.2
Other 43 4.9 − 12,599     6.6 −        12,642 6.6
Unknown 146 16.9 − 39,502     20.6 −        39,647 20.6
Population density of area of residence at diagnosis
f
500,000+ (Large Metropolitan) 461 53.4 16.1 157,157  82.0 23.7      157,618 81.8
50,000 - 499,999 (Metropolitan) 165 19.1 10.8 20,943     10.9 11.4        21,108 11.0
<50,000 (Nonmetropolitan) 223 25.9 7.5 12,204     6.4 7.4        12,427 6.5
Unknown 14 1.6 1,403       0.7           1,417 0.7
Residence at diagnosis in IHS service county
g
Yes 539 62.5 11.6 35,784     18.7 16.0        36,323 18.9
No 323 37.5 11.7 155,923  81.3 19.8      156,246 81.1
TOTAL
h
862 100 11.7 191,707  100 18.9      192,569 100
hBecause column totals for estimated numbers w ere calculated independently of the values for the subpopulations, values for each characteristic 
may not sum to the column total.
fPopulation density of area of residence is based on Metropolitan Statistical Areas (MSAs) as defined by the Office of Management and Budget.
Table 1.  Estimated number, percent and rate of diagnoses of HIV infection among American Indians and Alaska Natives 
(AI/AN) aged >13 years compared to the other race/ethnicity group, by selected characteristics, 2008-2011, United States
Note. The reported numbers have been statistically adjusted for reporting delays and missing risk factor information, but not incomplete reporting. 
aOther race/ethnicity group comprises: w hites, blacks/African Americans, Asians, Hispanics/Latinos, Native Haw aiians/other Pacif ic Islanders 
and multiple races, including American Indians and Alaska Natives of multiple race or w ith Hispanic ethnicity.
bAverage annual rate of HIV diagnoses per 100,000 population. Rates are not calculated by transmission category, facility type or unknow n area 
of residence because of lack of denominator data.
cHeterosexual contact w ith a person know n to have, or to be at high risk for, HIV infection.
AI/AN  Other Race/Ethnicity
a
dIncludes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identif ied.
eIncludes counseling and testing sites (CTS), sexually transmitted diseases clinics (STD), family planning, and other screening, diagnostic and 
referral agencies.
gIncludes persons residing in one of the 625 counties w here Indian Health Service (IHS) provides services. 
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Characteristic
No. % Rate
b No. % Rate
b
Sex
Male 2,351 73.8 265.9 650,775 75.1 524.1
Female 836 26.2 90.6 216,129 24.9 165.7
Age group in 2010 (yrs)
13-14 3 0.1 4.2 1,176 0.1 14.4
15-24 119 3.7 31.2 37,105 4.3 85.7
25-34 572 18 182.6 120,688 13.9 295.1
35-44 1,012 31.7 342.8 230,546 26.6 566.6
45-54 1,012 31.7 310.2 308,331 35.6 690.4
55-64 389 12.2 166.1 134,440 15.5 367.9
65+ 80 2.5 43.4 34,622 4 85.9
HIV transmission category - Male 
Male-to-male sexual contact 1,518 64.6 438,890 67.4
Injection drug use 259 11 86,257 13.3
Male-to-male sexual contact and injection drug use 382 16.2 48,332 7.4
Heterosexual contact
c 172 7.3 70,384 10.8
Other
d 20 0.8 6,912 1.1
HIV transmission category - Female
Injection drug use 266 31.8 53,948 25
Heterosexual contact
c 545 65.2 156,161 72.3
Other
d 25 3.1 6,021 2.8
Facility type at diagnosis
CTS/STD
e
465 14.6 94,693 10.9
Inpatient/ER 484 15.2 156,525 18.1
Outpatient 1,223 38.4 307,671 35.5
Other 228 7.2 60,546 7
Unknown/Missing 787 24.7 247,474 28.5
Population density of area of residence at diagnosis
f
500,000+ (Large Metropolitan) 1,957 61.4 289.1 718,672 82.9 430.6
50,000 - 499,999 (Metropolitan) 521 16.3 137.6 86,287 10 186.5
<50,000 (Nonmetropolitan) 663 20.8 88.3 53,243 6.1 128.5
Unknown 46 1.4 8,707 1
Residence at diagnosis in IHS service county
g
Yes 1,767 55.4 153.1 162,099 18.7 287.7
No 1,421 44.6 217.5 704,809 81.3 355.5
TOTALh 3,187 100 176.4 866,908 100 340.5
hBecause column totals for estimated numbers w ere calculated independently of the values for the subpopulations, values for each characteristic may not sum to 
the column total. For the other race/ethnicity group, sex w as missing for 4 persons and HIV transmission category w as missing for 3 males.
fPopulation density of area of residence is based on Metropolitan Statistical Areas (MSAs) as defined by the Office of Management and Budget (OMB). 
gIncludes persons residing in one of the 625 counties w here Indian Health Service (IHS) provides services. 
eIncludes counseling and testing sites (CTS), sexually transmitted diseases clinics (STD), family planning, and other screening, diagnostic and referral agencies.
Table 2. Estimated number, percent, and rate of American Indians and Alaska Natives (AI/AN) living with a diagnosis of HIV Infection at the 
end of 2010, compared to the other race/ethnicity group, aged >13 years, by selected characteristics, United States
AI/AN Other Race/ethnicity
a
Note. The reported numbers have been statistically adjusted for reporting delays and missing risk factor information, but not for incomplete reporting. 
bAnnual rate of HIV diagnoses per 100,000 population. Rates are not calculated by transmission category, facility type or unknow n area of residence because of 
lack of denominator data.
cHeterosexual contact w ith a person know n to have, or to be at high risk for, HIV infection.
dIncludes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identif ied.
aOther race/ethnicity group comprises: w hites, blacks/African Americans, Asians, Hispanics/Latinos, Native Haw aiians/other Pacif ic Islanders and multiple races, 
including American Indians and Alaska Natives of multiple race or w ith Hispanic ethnicity.
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Characteristic
Total
No. No. % No. % PR (95% C.I.) P value
d
Sex
Male 491 148 30.2 343 69.8 1.20 (0.89,1.62) 0.2388
Female 159 40 25.2 119 74.8 Referent
Age group at diagnosis (yrs)
13–24 89 15 16.4 75 83.6 Referent
25–34 225 48 21.5 176 78.5 1.31 (0.77,2.24) 0.3120
35–44 172 52 30.4 120 69.6 1.86 (1.10,3.12) 0.0197
45+ 164 73 44.6 91 55.4 2.72 (1.65,4.48) <0.0001
HIV Transmission category - Male
Male-to-male sexual contact 349 99 28.5 249 71.5 0.75 (0.50,1.13) 0.1680
Injection drug use 42 17 41.2 25 58.8 1.09 (0.65,1.13) 0.7391
Male-to-male sexual contact and injection drug use 53 14 25.7 39 74.3 0.68 (0.38,1.22) 0.1953
Heterosexual contact
e
47 17 37.1 29 62.9 Referent
Other
c,f
1 1 85.7 0 14.3 N/A
HIV Transmission category -  Female
Injection drug use 41 12 29.6 29 70.4 1.25 (0.70,2.21) 0.4516
Heterosexual contact
e 117 28 23.5 90 76.5 Referent
Other
c,f 1 0 68.7 0 31.3 N/A
Facility type at HIV diagnosis
CTS/STD
g
109 6 5.6 103 94.4 Referent
Inpatient/ER 140 79 56.5 61 43.5 10.1 (4.62, 22.30) <0.0001
Outpatient 247 69 27.9 178 72.1 5.00 (2.25,11.13) <0.0001
Other 34 9 25.9 26 74.1 4.66 (1.79,12.14) 0.0016
Unknown/Missing 120 26 21.3 94 78.7 3.82 (1.64,8.91) 0.0019
Population density of area of residence at diagnosis
h
500,000+ (Large Metropolitan) 340 96 28.1 244 71.9 Referent
50,000–499,999 (Metropolitan) 143 39 27.1 104 72.9 0.99 (0.72,1.36) 0.9565
<50,000 (Nonmetropolitan) 156 54 34.4 103 65.6 1.26 (0.96,1.66) 0.0989
Unknown
c
10 0 0 10 100 N/A
Residence at diagnosis in IHS service county
i
Yes 416 137 32.8 279 67.2 1.49 (1.13,1.96) 0.0050
No 234 52 22.1 182 77.9 Referent
Total
j
650 188 29.0 462 71.0
dStatistically signif icant if  p value <0.05.
aLate Diagnosis is defined as HIV Stage 3 (AIDS) diagnosis received <3 months of initial HIV diagnosis.
bHIV Stage 3 diagnosis >3 months after HIV diagnosis or no HIV Stage 3 (AIDS) diagnosis.
jBecause column totals for estimated numbers w ere calculated independently of the values for the subpopulations, values for each 
characteristic may not sum to the column total.
iIncludes persons residing in one of 625 counties w here Indian Health Service (IHS) provides services.
gIncludes counseling & testing sites (CTS), sexually transmitted diseases clinics (STD), family planning, & other screening, diagnostic and 
referral agencies.
fIncludes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identif ied.
eHeterosexual contact w ith a person know n to have, or to be at high risk for, HIV infection.
cPrevalence ratios exclude 'other' from male and female transmission categories and 'unknow n' from population density of area of residence 
because of small cell size.
hPopulation density of area of residence is based on Metropolitan Statistical Areas (MSAs) as defined by the OMB.
 Yes
a
Stage 3 (AIDS) within 3 months after HIV diagnosis
No
b
Note. The reported numbers have been statistically adjusted for reporting delays and missing risk factor information, but not incomplete 
reporting. 
Table 3.  Estimated number, percent and probability of late diagnosis of HIV infection among American Indians and 
Alaska Natives, aged >13 years, by selected characteristics, 2008-2010, United States  
Univariate Prevalence Ratio
c
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In the univariate analysis stratified by sex, AI/AN males had a higher probability of late 
diagnosis with increasing age; diagnosis in an inpatient/ER, outpatient facility or other facility; 
and residence in an IHS service county (Table 4).  In the multivariate model for AI/AN males, 
predictors of late diagnosis were age >35 years and diagnosis in an outpatient, inpatient/ER or 
other setting.  For females, the only significant predictor of late diagnosis in the univariate model 
was diagnosis in an inpatient/ER facility (PR 6.81, CI 1.82, 25.4, P = 0.0043).  
 
Characteristic Total Univariate Multivariate
No. No. % No. % PR (95% C.I.) PR (95% C.I.)
Age group at diagnosis (yrs)
13–24 73 11 15.7 62 84.3 Referent Referent
25–34 180 42 23.5 138 76.5 1.50(0.83,2.71) 1.30(0.74,2.29) 0.1830 0.3617
35–44 130 43 32.8 87 67.2 2.09(1.16,3.76) 1.79(1.03,3.13) 0.0136 0.0390
45+ 108 52 48 56 52.0 3.06(1.74,5.39) 2.44(1.43,4.16) 0.0001 0.0011
Facility Type at HIV Diagnosis
CTS/STD
d
86 5 5.8 81 94.2 Referent Referent
Inpatient/ER 101 60 59 41 41.0 10.1(4.27,23.94) 8.64(3.64,20.49) <0.0001 <0.0001
Outpatient 188 56 30 132 70.0 5.13(2.14,12.31) 4.59(1.92,10.98) 0.0002 0.0006
Other 27 8 28.7 19 71.3 4.92(1.75,13.83) 4.64(1.67,12.91) 0.0025 0.0033
Unknown/Missing 88 19 22 69 78.0 3.77(1.48,9.59) 3.33(1.31,8.45) 0.0053 0.0113
Residence at diagnosis in 
IHS service county
e
Yes 307 105 34.3 202 65.7 1.47(1.08,1.99) 1.14(0.85,1.53) 0.0134 0.3898
No 184 43 23.3 141 76.7 Referent Referent
Total
f
491 148 30.2 343 69.8
cStatistically signif icant if  p value 0.05.
eIncludes persons residing in one of 625 counties w here Indian Health Service (IHS) provides services.
bHIV Stage 3 diagnosis >3 months after HIV diagnosis or no HIV Stage 3 (AIDS) diagnosis.
aLate Diagnosis is defined as HIV Stage 3 (AIDS) diagnosis received <3 months of initial HIV diagnosis.
Stage 3 (AIDS) within 3 months 
after HIV diagnosis Prevalence Ratio
Yes
a
No
b
fBecause column totals for estimated numbers w ere calculated independently of the values for the subpopulations, values in each column may 
not sum to the column total.
dIncludes counseling and testing sites (CTS), sexually transmitted diseases clinics (STD), family planning, and other screening, diagnostic and 
referral agencies.
Table 4.  Estimated  number, percent and probability of late diagnosis of HIV infection among American Indian/ Alaska 
Native males, aged >13 years, by  selected characteristics, 2008-2010, United States
P  value
c 
 
Multivariate
P  value
c
Univariate
Note. The reported numbers have been statistically adjusted for reporting delays and missing risk factor information, but not for incomplete 
reporting. 
 
 
DISCUSSION 
General Findings  
Males, individuals aged 25-34 years, those diagnosed in an outpatient facility, individuals 
living in a large metropolitan area at diagnosis, and individuals living in an IHS service county 
accounted for the highest percentages of AI/AN diagnosed with HIV infection. The 
epidemiologic profile of HIV among AI/AN was similar to that of the other race/ethnicity group, 
with a few exceptions: the percentage of infections attributed to IDU was significantly higher for 
AI/AN females; the percentage of infections attributed to IDU and MSM/IDU was significantly 
higher for AI/AN males, while the percentage attributed to heterosexual contact was lower; and 
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AI/AN had 4 times the percentage of HIV-diagnosed persons living in a rural area at diagnosis, 
although rates of diagnosis of HIV infection were the same.  
Transmission Category 
The majority of diagnoses of HIV infections among AI/AN were among males, 
particularly among MSM, which is consistent with the disproportionate impact of HIV on MSM 
among all races/ethnicities (CDC, 2013a; Burks, et al. 2011). The relatively lower proportion of 
infections attributed to heterosexual contact among AI/AN males, compared to the other 
race/ethnicity group, was likely due to the higher percentage of infections attributed to IDU. 
Considering that over 28% of HIV infections diagnosed among AI/AN females were attributed 
to IDU and over 90% of diagnoses among males were attributed to MSM, IDU or both 
MSM/IDU, prevention counseling and HIV treatment may need to address both risk behaviors. 
IDU and other substance abuse among AI/AN of both sexes has been associated with poverty, 
unemployment and historical trauma and with sexual behaviors that increase HIV risk (CDC, 
2012c; NASTAD, 2004; Simoni, et al. 2004; Diamond, et al. 2001; Baldwin, et al. 1996).  While 
the number of new HIV infections due to IDU in the United States has decreased overall, likely 
due to substance abuse treatment and syringe exchange programs (Hall, et al. 2008), access to 
such risk-reduction programs may be especially challenging in rural areas, where many AI/AN 
live. Cultural norms, including reticence about discussing drug use or sexual activities, and 
stigma regarding homosexuality have been previously described (GAO, 2007) and could result in 
late diagnosis if HIV testing decisions are based on behavioral risk assessment in lieu of  testing 
as part of standard practice. Since 2006, consistent with CDC recommendations (Branson, et al. 
2006), IHS has supported and piloted universal routine testing for HIV, where allowed by local 
laws, and several tribal organizations have adopted supporting resolutions (IHS, 2012a; Reilley, 
et al. 2010). In addition to implementing universal HIV screening for all patients aged 13-64 
years, health care systems can develop culturally sensitive prevention counseling strategies for 
AI/AN, especially MSM and IDU, to identify persons who need more frequent HIV screening 
(Branson, et al. 2006). 
Late diagnosis 
The percentage of AI/AN diagnosed with Stage 3 HIV infection (AIDS) within 3 months 
of their HIV diagnosis (29%) was similar to that among HIV-infected persons in the other 
race/ethnicity category (27%), indicating the need for improvement in the coverage of testing 
efforts among both groups.  Early diagnosis and treatment maximizes the survival and prevention 
benefits of antiretroviral therapy (CDC, 2009; Hall, et al. 2006; Hall, 2012). It was expected that 
AI/AN diagnosed late would be older, similar to other studies for all races/ethnicities, because 
older age is a risk factor for HIV disease progression due to diminished immune function or 
presence of comorbid conditions, and because testing may be motivated by symptoms of Stage 3 
HIV infection (CDC, 2009; Hall, et al. 2006). The association of late diagnosis for males and 
females with diagnosis in a hospital or ER may be due to advanced disease with symptoms or 
requiring hospitalization.  
The higher probability of late diagnosis for residents of counties with IHS facilities, 
which was significant in the univariate analyses for all AI/AN and for males warrants exploration 
because the presence of I/T/U facilities is expected to increase convenient access to testing. 
However, testing must be perceived as a need by AI/AN and their providers, and be acceptable to 
AI/AN persons served by I/T/U facilities, to increase testing opportunities and test delivery 
(GAO, 2007; IHS, 2012a; Native Communities, 2004; Lapidus, et al. 2006).  IHS recommends 
that facilities consider methods to improve HIV testing among males and has piloted universal 
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screening for females and males in some IHS facilities, with some tribal support.  IHS also has 
strived to increase routine testing by adding quality-of-care performance measures to IHS 
clinical databases to indicate date of last HIV test for patients aged 13-64 years and to calculate 
the proportion of eligible patients who have not been tested (IHS, 2012a; IHS, 2013) , which is 
likely to increase testing for both AI/AN males and females.   
Among the other race/ethnicity group, males whose HIV infections were attributed to 
MSM and MSM/IDU had a lower probability of late diagnosis than heterosexuals (CDC, 2013a; 
Helms, et al. 2009), reflecting more frequent testing behaviors in these groups, but there was no 
statistically significant difference for AI/AN MSM and MSM/IDU in our study.  This result may 
be due to factors that could include greater stigma in AI/AN communities, a lack of accessible 
testing venues for frequent testers, or concerns about confidentiality, particularly on tribal lands 
(GAO, 2007; NASTAD, 2004; Lapidus, et al. 2006).  
AI/AN females, consistent with findings among females generally, likely have more 
testing opportunities than males when they receive prenatal care, seek family planning services, 
have annual cervical cancer screening or attend other medical visits (GAO, 2007; IHS, 2012a; 
CDC, 2009). In addition, in 2006, IHS implemented HIV screening recommendations for all 
pregnant women. Additionally, enhanced HIV and STD screening was recommended as a 
follow-up to any positive STD test for all females and males (Branson, et al. 2006; IHS, 2012a). 
The IHS also instituted quality indicators in IHS facilities, which resulted in substantial increases 
in prenatal HIV screening during 2006-2011 (GAO, 2007; IHS, 2013; Reilley, et al. 2010).  
While HIV diagnosis rates were more than twice as high for AI/AN residing in 
metropolitan  than in rural areas, more than 25% of AI/AN diagnosed with HIV resided in rural 
areas, demonstrating that HIV is not only an urban concern for Native Americans.  Forty one 
percent of AI/AN adults and adolescents lived in rural areas in 2010, compared to 16% of the 
other race/ethnicity group (U.S. Census, 2012b). Native American communities in rural areas 
offer factors than can strengthen HIV care and prevention, including strong family, tribal and 
community ties, spirituality, traditionalism, and cultural practices (NASTAD, 2004; Native 
Communities, 2004). On the other hand, rural residence for large numbers of AI/AN can present 
challenges for HIV prevention, testing, and linkage to care and treatment, because of geographic 
isolation, limited resources, reduced access to care, confidentiality concerns, stigma, and poverty 
(GAO, 2007; NASTAD, 2004; Reilley, et al. 2010; Native Communities, 2004; Rural, 2009).  
HIV Prevention Efforts  
A number of federal, state, tribal and community-based organizations have conducted 
culturally appropriate campaigns to increase awareness of HIV risk and promote HIV testing 
among AI/AN (NASTAD 2004; IHS, 2012a; IHS, 2012b; ANTHC, 2013). Social marketing 
approaches are underway to raise HIV and STD awareness among AI/AN, especially because of 
high rates of STDs among some AI/AN (CDC, 2012a). There are also campaigns to combat the 
stigma attached to being a “Two Spirit” male (gay, bisexual, or transgendered) and to HIV 
testing in general (Burks, et al. 2011; NNAAPC, 2012). Such efforts could reduce the number of 
late diagnoses among AI/AN, improve survival, and prevent further transmission, because 
studies show that persons who are aware of their HIV infection are more likely to reduce the risk 
behaviors that transmit the virus to others (CDC, 2009; Hall, et al. 2006; Marks, et al. 2005). 
CDC’s High-Impact HIV Prevention (HIP) approach emphasizes HIV testing and linkage to and 
retention in care as well as treatment early in HIV infection. This is likely to improve health 
outcomes as well as prevent transmission of the virus to others (CDC, 2011; Cohen, et al. 2011). 
The National HIV/AIDS Strategy (NHAS) calls for reducing new HIV infections, increasing 
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access to care and improving health outcomes for people living with HIV, and reducing HIV-
related health disparities (ONAP, 2010). In accordance with NHAS, CDC has recommended 
improvements in HIV surveillance efforts in AI/AN communities (CDC, 2013b).  
Limitations 
This report is subject to several limitations. Hispanic and multi-race AI/AN were 
included in the other race/ethnicity group to be consistent with CDC HIV Surveillance Reports 
which use mutually-exclusive race/ethnicity categories (CDC 2013a); therefore these estimates 
for AI/AN do not fully represent the burden of HIV in AI/AN communities. In the 2010 Census, 
44 percent of persons who identified as AI/AN reported being AI/AN in combination with one or 
more other races (U.S. Census 2012a). Some underreporting of HIV may have occurred due to 
confusion about case reporting responsibilities for persons diagnosed on tribal lands or in a state 
other than his or her state of residence (NASTAD, 2004).  In addition, there is evidence of 
misidentification of race/ethnicity for AI/AN in some surveillance systems, varying from 3.5% to 
55%, that may lead to underestimation of HIV rates among AI/AN (NASTAD, 2004; Bertolli, et 
al. 2007), particularly in urban areas. It also should be noted that AI/AN residing in IHS service 
counties at the time of diagnosis may have been diagnosed in non-IHS facilities or diagnosed 
outside of those counties. Because information identifying reporting facilities of specific tribal 
health systems was not consistently collected by the national HIV surveillance system during 
2008-2011, the percentage of AI/AN initially diagnosed with HIV infection at tribal health 
system facilities is not known. Statistical results comparing a relatively small population 
(AI/AN) to the extremely large other race/ethnicity group must be interpreted carefully because 
the relative uncertainty for an estimate of small proportion is large.  
 
CONCLUSION 
AI/AN at risk for HIV infection present unique needs and opportunities for HIV 
prevention. Increased routine HIV testing for AI/AN living in rural as well as larger metropolitan 
areas at a variety of public health clinics and outpatient facilities could reduce stigma and 
prevent late diagnoses. Better identification of AI/AN would contribute to improved HIV 
surveillance and prevention, especially in urban areas. Higher percentages of injection drug use 
among HIV-infected AI/AN is an indication for the provision of HIV prevention and treatment 
services integrated with substance abuse rehabilitation and outreach tailored to this population. 
Early detection of HIV infection along with linkage to and retention in care are needed for 
AI/AN, especially among MSM and IDU, to decrease HIV transmission and improve survival. 
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